Effects of fenofibrate in patients with type 2 diabetes mellitus complicated by diabetic neuropathy

por Olga Nikolaevna Tkacheva, Irina Mikhailovna Novikova, Natalya Viktorovna Sharashkina, Khyadi Magometovna Torshkhoeva, Nadezhda Konstantinovna Runikhina
Publicado 2010

Novel electrosprayed nanospherules for enhanced aqueous solubility and oral bioavailability of poorly water-soluble fenofibrate

por Yousaf AM, Mustapha O, Kim DW, Kim DS, Kim KS, Jin SG, Yong CS, Youn YS, Oh YK, Kim JO, Choi HG
Publicado 2016

CLINICAL EFFICACY AND SAFETY OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA AGONISTS IN RHEUMATOID ARTHRITIS: AN OPEN-LABEL CONTROLLED STUDY

por V. S. Shirinsky, O. A. Polovnikova, N. Yu. Kalinovskaya, I. V. Shirinsky
Publicado 2014

Fenofibrate prevents nicotine-induced acute kidney injury: Possible involvement of endothelial nitric oxide synthase

por Vishal Arvind Chakkarwar, Pravin Kawtikwar
Publicado 2021

Pleiotropic effects of fenofibrate: focus on type 2 diabetes mellitus

por Alexander Sergeevich Ametov, Marina Alexandrovna Prudnikova
Publicado 2014

Prospects for the management of diabetic neuropathy

por Alexandr Sergeevich Ametov, Marina Alexandrovna Lysenko
Publicado 2011

Aminoclay–lipid hybrid composite as a novel drug carrier of fenofibrate for the enhancement of drug release and oral absorption

por Yang L, Shao Y, Han HK
Publicado 2016

PLEIOTROPIC EFFECTS OF SIMVASTATIN AND FENOFIBRATE IN PATIENTS WITH RHEUMATOID ARTHRITIS: A COMPARATIVE STUDY

por I. V. Shirinsky, N. Yu. Kalinovskaya, V. S. Shirinsky
Publicado 2019

Pleiotropic effects of PPAR-α – from benchside to bedside

por I. V. Shirinsky, V. S. Shirinsky
Publicado 2021

Supersaturable solid self-microemulsifying drug delivery system: precipitation inhibition and bioavailability enhancement

por Quan G, Niu B, Singh V, Zhou Y, Wu C, Pan X, Wu C
Publicado 2017

Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug

por Moshin K, Alamri R, Ahmad A, Raish M, Alanazi FK, Hussain MD
Publicado 2016

Non- high-density lipoprotein cholesterol and cardiovascular disease in patients with diabetic dyslipidaemia

por Alberto Zambon
Publicado 2020